| Effect | Increase |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 60 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight |
The addition of 200mcg chromium (as chloride) to milk powder, relative to a milk powder placebo, in type II diabetics already on medication (gliclazide) noted that there was a reduction in blood glucose, insulin, and improvement in insulin sensitivity over the course of 16 weeks in men only.
Acute insulin response following an oral glucose tolerance test (10 minutes after) was unaffected in both sexes.
